Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2026)
Twist Bioscience has reported Other Non-Current Liabilities over the past 9 years, most recently at $746000.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 65.41% to $746000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $746000.0 through Mar 2026, up 65.41% year-over-year, with the annual reading at $747000.0 for FY2025, 83.54% up from the prior year.
- Other Non-Current Liabilities was $746000.0 for Q1 2026 at Twist Bioscience, up from $741000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $8.1 million in Q1 2022 and troughed at $60000.0 in Q3 2022.
- The 5-year median for Other Non-Current Liabilities is $475000.0 (2023), against an average of $976352.9.
- The largest YoY upside for Other Non-Current Liabilities was 1830.57% in 2022 against a maximum downside of 99.79% in 2022.
- A 5-year view of Other Non-Current Liabilities shows it stood at $60000.0 in 2022, then skyrocketed by 691.67% to $475000.0 in 2023, then dropped by 14.32% to $407000.0 in 2024, then surged by 82.06% to $741000.0 in 2025, then grew by 0.67% to $746000.0 in 2026.
- Per Business Quant, the three most recent readings for TWST's Other Non-Current Liabilities are $746000.0 (Q1 2026), $741000.0 (Q4 2025), and $747000.0 (Q3 2025).